Mark N. Tompkins 13D/13G Filings for

Mark N. Tompkins 13D and 13G filings for :

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-02-14
4:00 pm
Purchase
2024-12-3113GLomond Therapeutics Holdings, Inc.Mark N. Tompkins1,187,500
4.000%
1,187,500increase
(New Position)
Filing